2024-09-18 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, offering a wide range of medical and surgical services.

**Performance Analysis:**

**1.  Outperformance vs. S&P 500:**
    * **HCA's cumulative return:** 172.15%
    * **S&P 500 (VOO) cumulative return:** 88.56%
    * **Relative Outperformance:** 83.59% (97.76% percentile)

    HCA has significantly outperformed the S&P 500, exhibiting a remarkable 83.59% outperformance. This strong relative performance places HCA in the 97.76th percentile of historical outperformance, indicating a strong historical track record.

**2. Recent Price Movement:**

    * **Closing Price:** 399.33
    * **5-day Moving Average:** 395.55
    * **20-day Moving Average:** 390.31
    * **60-day Moving Average:** 358.1

    HCA's price is currently trading above all three moving averages, indicating bullish momentum and potential for further upside.

**3. Technical Indicators:**

    * **RSI:** 59.94 (Neutral)
    * **PPO:** -0.21 (Slightly Negative)
    * **Delta_Previous_Relative_Divergence:** 0.8 (Positive)
    * **Expected Return:** 1.94% (5-year projected return)

    The RSI indicates neutral momentum, while the PPO suggests a slight slowdown in price gains. The positive delta_previous_relative_divergence suggests potential for a continued short-term uptrend. The expected return of 1.94% reflects potential for growth over the next five years.

**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue | Notes |
| ---------- | ------ | -------- | ----- |
| 2024-07-29 | 5.6   | 17.49 B$ |  |
| 2024-05-02 | 6.01  | 17.34 B$ |  |
| 2023-10-26 | 3.98  | 16.21 B$ |  |
| 2023-08-02 | 4.35  | 15.86 B$ |  |
| 2024-07-29 | 4.35  | 15.86 B$ |  |

HCA has consistently delivered strong earnings growth, exceeding analyst expectations in the most recent quarter. Revenue growth has also been robust, demonstrating the company's strong market position and growth potential.

**5. Overall Conclusion:**

HCA exhibits a strong performance track record, with consistent outperformance against the S&P 500. The stock is currently trading above its moving averages, indicating bullish momentum. Technical indicators suggest continued upside potential, while strong earnings growth and revenue expansion support this positive outlook. The expected return further emphasizes the company's potential for growth over the long term.
